| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74b7b50944d8e1960440fb1f5440b7fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c84d8692393faaf7bb5f1681d435a1c8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
| filingDate |
2006-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3737e6146d3817f9e1eb0acf71aa59e |
| publicationDate |
2007-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007002571-A2 |
| titleOfInvention |
Use of an anti c5 complement antibody to treat patients with sickle cell disease |
| abstract |
A method of treating a sickle cell patient with an anti C5 complement antibody is disclosed. Treatment with said antibody decreases the extent of red blood cell lysis and decreases the consequential clinical sequelae. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2359834-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10703809-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109045296-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-201600121482-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023023220-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10590189-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9725504-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9718880-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9732149-B2 |
| priorityDate |
2005-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |